Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS: ANTH · Delayed Price · USD
0.0000
-0.0001 (-99.00%)
Jan 2, 2024, 3:32 PM EDT - Market closed

Anthera Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201720162015201420132012 2011 - 2005
Net Income
0000-16.94-53.6-34.91-30.31-33.11-59.4
Upgrade
Depreciation & Amortization
00000.280.270.290.340.350.33
Upgrade
Share-Based Compensation
00004.386.743.542.183.150.96
Upgrade
Other Operating Activities
-----24.63-2.320.182.19-2.3-15.53
Upgrade
Operating Cash Flow
0000-36.9-48.92-30.91-25.6-31.91-73.64
Upgrade
Capital Expenditures
00000-0.77-0.080-0.02-0.21
Upgrade
Change in Investments
---------5.33-17.77
Upgrade
Other Investing Activities
-------100.6614.19
Upgrade
Investing Cash Flow
00000-0.77-0.0810-4.69-3.78
Upgrade
Common Stock Issued
000018.256.7375.310.3945.7935.76
Upgrade
Other Financing Activities
-----16.84--18.09-2.67-4.51
Upgrade
Financing Cash Flow
000018.2523.5875.3-7.7143.1231.26
Upgrade
Net Cash Flow
0000-18.65-26.1144.31-23.316.52-46.19
Upgrade
Free Cash Flow
0000-36.9-49.69-30.99-25.6-31.93-73.84
Upgrade
Free Cash Flow Margin
------34265.52%-972.90%---
Upgrade
Free Cash Flow Per Share
-----3.59-9.62-6.96-9.41-13.98-81.76
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.